All three Myc signatures were prognostic among luminal breast cancer samples in METABRIC as well (Fig. 5d–f), and multivariable analyses accounting for age, tumor size, nodal status, and HER2 status showed two out of three Myc signatures were still significantly prognostic (Additional file 2: Table S5). The gene discussed is ERBB2; the disease is neoplasm.